Skip to Content

GX 623 (Ziagen 300 mg)

Generic Name: abacavir

Pill with imprint GX 623 is Yellow, Elliptical / Oval and has been identified as Ziagen 300 mg. It is supplied by GlaxoSmithKline.

Ziagen is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Ziagen 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GX 623

Ziagen 300 mg GX 623
Ziagen 300 mg GX 623
Ziagen 300 mg GX 623

Ziagen

Generic Name:
abacavir
Imprint:
GX 623
Strength:
300 mg
Color:
Yellow
Size:
18.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
hypromelloses
polysorbate 80
ferric oxide yellow
triacetin
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide